Soluble Fas-ligand levels in bronchoalveolar lavage fluid before and after interferon-γ-1b treatment in idiopathic pulmonary fibrosis

M. Plataki, K. M. Antoniou, M. G. Alexandrakis, K. Sfiridaki, N. Tzanakis, E. Tzortzaki, N. M. Siafakas, D. Bouros (Heraklion, Alexandroupolis, Greece)

Source: Annual Congress 2005 - Various aspects of pulmonary fibrosis
Session: Various aspects of pulmonary fibrosis
Session type: Thematic Poster Session
Number: 2190
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Plataki, K. M. Antoniou, M. G. Alexandrakis, K. Sfiridaki, N. Tzanakis, E. Tzortzaki, N. M. Siafakas, D. Bouros (Heraklion, Alexandroupolis, Greece). Soluble Fas-ligand levels in bronchoalveolar lavage fluid before and after interferon-γ-1b treatment in idiopathic pulmonary fibrosis. Eur Respir J 2005; 26: Suppl. 49, 2190

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Elevated NT-3 levels in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis
Source: Eur Respir J 2007; 30: Suppl. 51, 586s
Year: 2007

Calgranuline B in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009


Cytokine profiles of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysema
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012


The coagulation and antifibrynolitic activities are increased in the bronchoalveolar lavage fluid from patients with progressing idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 575s
Year: 2007

Induced sputum versus bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2003; 22: Suppl. 45, 227s
Year: 2003

The decrease of surfactant protein D in bronchoalveolar lavage fluid in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012

Increased Clara cell protein 16 levels in the bronchoalveolar lavage fluid of idiopathic pulmonary fibrosis patients
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008

CCR5 expression and CC-chemokine levels in broncho-alveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2002; 20: Suppl. 38, 598s
Year: 2002

Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Promising biomarkers for idiopathic interstitial pneumonia
Year: 2020




Increased myeloid dendritic cells in the bronchoalveolar lavage fluid of idiopathic pulmonary fibrosis patients
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008

Fibrocytes are detected in bronchoalveolar lavage (BAL) fluid in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011


ECP and EPX in bronchoalveolar lavage fluid in children with cystic fibrosis and mild lung disease
Source: Eur Respir J 2001; 18: Suppl. 33, 538s
Year: 2001

The effect of MUC5B promoter polymorphism on susceptibility to idiopathic interstitial pneumonias and cell profiles in bronchoalveolar Lavage fluid
Source: International Congress 2015 – IPF pathogenesis
Year: 2015

Concentration of sFas in bronchoalveolar lavage fluid of smoking patients with sarcoidosis
Source: Annual Congress 2012 - Sarcoidosis
Year: 2012



Bronchoalveolar lavage in idiopathic pulmonary fibrosis
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017

CCL20 level in bronchoalveolar lavage fluid is correlated with the levels of serum indications in patients with pulmonary sarcoidosis
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010


Changes of BAL findings as no progression marker in idiopathic pulmonary fibrosis (IPF) patients treated with IFN-g
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006


CD163 positive alveolar macrophages from bronchoalveolar lavage in idiopathic pulmonary fibrosis and lung cancer.
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019

Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005


Analysis of cellular components of bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis and pulmonary sarcoidosis: focus on lymphocyte and macrophage subpopulations
Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond
Year: 2008